Mustang Bio Inc (MBIO)
0.316
+0.02
(+5.30%)
USD |
NASDAQ |
May 17, 16:00
0.316
0.00 (0.00%)
After-Hours: 20:00
Mustang Bio Shareholders Equity (Quarterly): 0.123M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.123M |
| September 30, 2023 | 4.009M |
| June 30, 2023 | 13.71M |
| March 31, 2023 | 29.82M |
| December 31, 2022 | 46.27M |
| September 30, 2022 | 64.32M |
| June 30, 2022 | 82.01M |
| March 31, 2022 | 97.33M |
| December 31, 2021 | 112.40M |
| September 30, 2021 | 122.21M |
| June 30, 2021 | 135.02M |
| March 31, 2021 | 133.36M |
| December 31, 2020 | 98.44M |
| September 30, 2020 | 76.42M |
| June 30, 2020 | 71.03M |
| Date | Value |
|---|---|
| March 31, 2020 | 45.80M |
| December 31, 2019 | 51.65M |
| September 30, 2019 | 62.45M |
| June 30, 2019 | 71.44M |
| March 31, 2019 | 28.48M |
| December 31, 2018 | 36.40M |
| September 30, 2018 | 44.99M |
| June 30, 2018 | 51.60M |
| March 31, 2018 | 55.64M |
| December 31, 2017 | 59.83M |
| September 30, 2017 | 65.09M |
| June 30, 2017 | 69.07M |
| March 31, 2017 | 74.21M |
| December 31, 2016 | 24.28M |
| September 30, 2016 | 3.322M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.123M
Minimum
Dec 2023
135.02M
Maximum
Jun 2021
69.36M
Average
71.03M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
| Fortress Biotech Inc | 23.02M |
| Avinger Inc | -6.202M |
| AIM ImmunoTech Inc | 10.23M |
| Protalix BioTherapeutics Inc | 29.79M |
| Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.74M |
| Total Liabilities (Quarterly) | 17.62M |